Rheumatology

Charles-Schoeman C, Oelke K, Saffore CD, Kadakia A, Peng Y, Fang S, Markley G, Bergman MJ. Effectiveness of Upadacitinib Versus Other Advanced Therapies in Rheumatoid[...]

By afschroeder • November 4, 2026

Kim GHJ, Song JW, Weigt SS, Kim J, Calais J, Hotta M, Fishbein GA, Rerkpichaisuth V, Teng PY, Oh JH, Chung A, Volkmann ER, Oh[...]

By afschroeder • October 31, 2026

Bond M, Hysa E, Konzett V, van der Geest KSM, Sattui SE, Amudala N, Fruth M, Gheysens O, Helliwell T, Josten C, Keller KK, Kermani[...]

By afschroeder • October 28, 2026

Good SD, England BR, Volkmann ER. The Nuances of Cost-Related Medication Non-Adherence in Patients Receiving Immunosuppression Compared to Patients with Chronic Disease: A Cross-Sectional Study.[...]

By afschroeder • October 27, 2026

Aung T. Inflammatory Eye Disease and Immunosuppressive Therapy: A Rheumatologist's Perspective. Cureus. 2026 Sep 24;18(9):e116847. doi: 10.7759/cureus.116847. PMID: 42927373; PMCID: PMC13695429.

By afschroeder • October 26, 2026

Huang M, Zheng S, Du G, Zhou Z, Li X, Chen Y, Chen Q, Hu S, Lin J, Zheng K, Zhang W, Lin Q, Ruaro[...]

By afschroeder • October 25, 2026

Shye M, Sircar AD, Malchira R, Schulze C, Martin WJ. Successful Treatment of an Atypical Mycobacterial Exit Site Infection in a Patient on Peritoneal Dialysis:[...]

By afschroeder • October 16, 2026

Coziahr K, Sayles H, Johnson TM, Baker JF, Roul P, Cannon GW, Kunkel GA, Wysham KD, Kerr GS, Razmjou AA, Smith I, Barton JL, Danila[...]

By afschroeder • October 9, 2026

Bae SS, Rivero Gallegos D, Bozan F, Sambataro G, Dourado E, Zanframundo G, Ventura IB, Yoshida A, Faghihi-Kashani S, Loganathan A, Bonella F, Gonzalez-Gay MA,[...]

By afschroeder • September 30, 2026

Enke JS, Barton AK, Kimura K, Calais J, Unterrainer L, Volkmann E. Fibroblast Activation Protein-Directed PET: Expanding FAPI Beyond Cancer. AJR Am J Roentgenol. 2026[...]

By afschroeder • September 24, 2026